Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medihoney is a specialized medical technology brand focused on the development and commercialization of medical-grade honey products for advanced wound care. The company's products are based on standardized Leptospermum (Manuka) honey, which provides a unique combination of antibacterial activity, low pH, and high osmolarity to promote healing. Medihoney dressings are clinically proven to facilitate autolytic debridement and create an optimal moist environment for chronic and acute wounds. Originally an independent Australian entity, the Medihoney brand was acquired by Derma Sciences, which was later integrated into Integra LifeSciences. Today, it remains a gold standard in honey-based therapeutic interventions for burns and ulcers. The product line includes various formats such as gels, pastes, and impregnated dressings to suit different wound types.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medihoney.